Summary
For Year 2026-27, Aarti Pharmalabs reports the following shareholding: Total Promoters at 43.1%, Mutual Fund at 1.09%, Insurance at 5.3%, Foreign Institutional Investors at 7.68%, Domestic Institutional Investors at 1.28%, and Retail at 41.54%. This breakdown provides a quick snapshot of ownership distribution for Aarti Pharmalabs in 2026-27.
Aarti Pharmalabs FAQs
As of 04-2026, the promoter shareholding in Aarti Pharmalabs stands at 43.1% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Aarti Pharmalabs is 7.68% and 1.28% respectively.
The retail shareholding of the Aarti Pharmalabs is 41.54%.
Changes in shareholding patterns of Aarti Pharmalabs can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Aarti Pharmalabs are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
